Xontogeny, accelerator launched by former Sarepta CEO, preps five new biotechs

After news that one of the biotechs at Chris Garabedian’s Back Bay-based accelerator, Landos, got a $60M Series B round, he says it’s incubating five others, one of which just closed a Series A round.